Veristat Parent LP data breach

Clerk's notes

Veristat Parent LP has officially reported a data breach incident to the New Hampshire Attorney General. The filing, dated May 20, 2025, confirms that the company, which specializes in clinical research, has identified an event where unauthorized access to its systems may have occurred. The details surrounding the nature of this breach are currently under investigation.

While the specific categories of information involved were not detailed in the public record, the report indicates that personal information was potentially exposed. Individuals who received a notification letter from Veristat Parent LP are advised that their data was likely part of the compromised set.

If you received such a letter, it is crucial to review it thoroughly. The notification should provide available details about the incident and any identity monitoring services offered. Remain vigilant for any suspicious communications or activity that could indicate misuse of your information.

Given Veristat Parent LP's role as a clinical research organization, they routinely handle sensitive data related to their operations. This includes various forms of personal information collected to support pharmaceutical, biotechnology, and medical device studies.

Receiving a data breach notification can be concerning. Understanding the implications of such an event is an important step in protecting yourself. For those affected by the Veristat Parent LP data breach, assessing your options is key.

If you believe your personal information was compromised in this incident and have questions about your rights or potential recourse, you may wish to seek a complimentary case review.

If a notification letter about this breach reached you, see every New Hampshire data breach on file or browse all cases.